Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.

18
Number of overlapping holdings
60.0%
% of FBT's 31 holdings also in BBP
29.5%
% of BBP's 65 holdings also in FBT
Overlap by Weight
Sector Drift (FBT minus BBP)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
Company | Weight in FBT |
Weight in BBP |
Overlap | |
---|---|---|---|---|
ALNYLAM PHARMACEUTICALS INC | 2.9% | 2.1% | 2.1% | |
ACADIA PHARMACEUTICALS INC | 3.9% | 1.9% | 1.9% | |
GILEAD SCIENCES INC | 3.6% | 1.8% | 1.8% | |
UNITED THERAPEUTICS CORP | 3.4% | 1.7% | 1.7% | |
INTRA-CELLULAR THERAPIES INC | 3.7% | 1.7% | 1.7% |
Position Highlights (Non-Overlapping Exposures)
FBT Overweight Relative to BBP
NATERA INC | 4.3% | |
CORCEPT THERAPEUTICS INC | 4.1% | |
ARGENX SE ADR | 3.8% | |
REPLIGEN CORP | 3.8% | |
CATALYST PHARMACEUTICAL PART | 3.6% | |
WATERS CORP | 3.6% | |
ALKERMES PLC | 3.6% | |
ILLUMINA INC | 3.3% | |
BRUKER CORP | 3.0% | |
METTLER-TOLEDO INTERNATIONAL | 3.0% |
FBT Underweight Relative to BBP
MIRUM PHARMACEUTICALS, INC. | -2.4% | |
TRAVERE THERAPEUTICS, INC. | -2.0% | |
LIGAND PHARMACEUTICALS-CL B | -1.9% | |
LEXICON PHARMACEUTICALS, INC. | -1.9% | |
LEGEND BIOTECH CORPORATION SPONSORED | -1.9% | |
BIOCRYST PHARMACEUTICALS INC | -1.8% | |
IONIS PHARMACEUTICALS, INC. | -1.8% | |
DAY ONE BIOPHARMACEUTICALS, INC. | -1.8% | |
TG THERAPEUTICS INC | -1.8% | |
ADMA BIOLOGICS, INC. | -1.8% |